Results 131 to 140 of about 38,243 (258)
TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk
The systematic approach in elucidating the gain‐of‐function (GOF) roles of TP53 mutations in early liver carcinogenesis. Unique downstream targets of TP53 L3 mutations were identified from chormatin immunoprecipitation sequencing in HCC cell lines, followed by a series of validation assays to substantiate the exclusive transcriptional regulations ...
Yin Kau Lam +10 more
wiley +1 more source
INFECCIÓN POR VIRUS DE LA HEPATITIS C EN LA UNIDAD DE DIÁLISIS
La hepatitis C, identificada en 1989, constituye un serio problema de salud, del que se conoce poco1, aunque ha sido objeto de investigación en todas las latitudes del planeta. Se estima que unas 170 millones de personas estén infectadas en todo el mundo, por lo que puede considerarse una pandemia viral2,3, con una prevalencia muy variable.
Luis A. Santos Pérez +2 more
openaire +1 more source
Ceftriaxone‐induced liver injury: Incidence, phenotypic characterization and predictive factors
Introduction Ceftriaxone is a widely used third‐generation cephalosporin in hospitalized patients. Although generally considered safe, it has been associated with hepatobiliary complications and emerging reports of drug‐induced liver injury (DILI). However, data on its true incidence, phenotypic patterns, and predictors remain limited. This study aimed
Mohamed Hatem +5 more
wiley +1 more source
AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Hepatology, EarlyView.
Robert J. Fontana +6 more
wiley +1 more source
Leveraging corona virus disease 2019 vaccination to promote hepatitis C screening
Abstract Health care initiatives, such as hepatitis C virus (HCV) screening, have been greatly overshadowed by the corona virus disease 2019 (COVID‐19) pandemic. However, COVID‐19 vaccination programs also provide an opportunity to engage with a high volume of people in a health care setting.
Aaron Vanderhoff +17 more
wiley +1 more source
Cystic fibrosis transmembrane conductance regulator (CFTR) modulators are widely used in patients with cystic fibrosis and significantly improve respiratory function and quality of life. However, their effectiveness may be limited by liver damage, which sometimes leads to treatment discontinuation, and the mechanisms underlying this remain poorly ...
Clara Laffitte Redondo +12 more
wiley +1 more source
Abstract Cardiovascular disease is a leading complication after both liver and kidney transplantation. Factors associated with and rates of cardiovascular events (CVEs) after simultaneous liver–kidney transplant (SLKT) are unknown. This was a retrospective cohort study of adult SLKT recipients between 2002 and 2017 at six centers in six United Network ...
Jennifer Jo +19 more
wiley +1 more source
COMPORTAMIENTO DE LA INFECCIÓN POR EL VIRUS DE LA
Para conocer el comportamiento de la infección por el virus de la hepatitis C en pacientes oncopediátricos, nos propusimos determinar la frecuencia de positividad al anti VHC en este grupo de pacientes, y describir el diagnóstico laparoscópico e ...
Dr. Rodolfo Valdés Landaburo +4 more
doaj
Abstract Aim Non‐surgical treatment of acute liver failure (ALF) is primarily supportive and depends on the underlying cause. While N‐acetylcysteine (NAC) is proven effective in paracetamol‐induced ALF, its potential benefits in non‐paracetamol ALF for paediatric patients remain unclear.
Alise D. E. de Groot +7 more
wiley +1 more source
Infección por hepatitis C: Enfoque para dermatólogos
La infección por el virus de la hepatitis C (VHC) es una epidemia mundial importante, causada por un virus RNA que produce tres tipos de péptidos que lo conforman y garantizan su variabilidad. La forma principal de adquisición es a través del uso de
Ximena Hormaza
doaj

